On September 27, 2024, Nyxoah SA reported results from their DREAM U.S. pivotal study, showing a 71.0% median reduction in Apnea-Hypopnea Index (AHI) for supine positions after 12 months, demonstrating significant quality-of-life improvements for participants. Notably, 73 out of 115 patients achieved AHI responder status, indicating a 63.5% success rate in treating sleep apnea.